Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.

Saved in:
Bibliographic Details
Title: Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.
Authors: Desai JV; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Urban A; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Swaim DZ; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Colton B; Pharmacy Department, NIH Clinical Center, NIH, Bethesda, MD, USA., Kibathi LW; Pharmacy Department, NIH Clinical Center, NIH, Bethesda, MD, USA., Ferrè EMN; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Stratton P; Office of the Clinical Director, National Institute of Neurological Disease and Stroke, NIH, Bethesda, MD, USA., Merideth MA; National Human Genome Research Institute, NIH, Bethesda, MD, USA., Hunsberger S; Biostatistics Research Branch, Division of Clinical Research (DCR), NIAID NIH, Bethesda, MD, USA., Matkovits T; Matinas BioPharma Nanotechnologies Inc., Bedminster NJ, USA., Mannino R; Matinas BioPharma Nanotechnologies Inc., Bedminster NJ, USA., Holland SM; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Tramont E; NIAID, NIH, Bethesda, MD, USA., Lionakis MS; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Freeman AF; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Jul 19; Vol. 66 (7), pp. e0030822. Date of Electronic Publication: 2022 Jun 14.
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first